1
In a statement, AstraZeneca Chairman Leif Johansson acknowledged Pfizer's decision. AstraZeneca repeatedly rejected Pfizer's provides, insisting they considerably undervalued the corporate and its portfolio of experimental drugs.

Comments

Who Upvoted this Story